“We May Bend, But Never Break”: How the Chandler Family Faces a Tuberous Sclerosis Complex (TSC) Diagnosis with Resilience

Gavin Chandler loves toy cars, watching Big City Greens, fans, the “Baby Shark” song, and anything that lights up or makes noise—including, his mother Jessica shares, the vacuum cleaner. He…

Continue Reading “We May Bend, But Never Break”: How the Chandler Family Faces a Tuberous Sclerosis Complex (TSC) Diagnosis with Resilience
Tuberous Sclerosis Complex: CBD Oral Solution Epidiolex Approved to Treat Seizures
source: pixabay.com

Tuberous Sclerosis Complex: CBD Oral Solution Epidiolex Approved to Treat Seizures

According to a story from GlobeNewswire, the biopharmaceutical company GW Pharmaceuticals plc recently announced that its CBD oral solution Epidiolex® has recently been approved as a treatment for seizures associated…

Continue Reading Tuberous Sclerosis Complex: CBD Oral Solution Epidiolex Approved to Treat Seizures

Updates from Marinus on Ganaxolone Trials for 3 Forms of Epilepsy

Marinus Pharmaceuticals has recently announced updates on its ganaxolone programs for tuberous sclerosis complex (TSC), PCDH19-related epilepsy (PCDH19-RE), and CDKL5 deficiency disorder (CDD). Ganaxolone Ganaxolone is a positive allosteric modulator…

Continue Reading Updates from Marinus on Ganaxolone Trials for 3 Forms of Epilepsy
Ganaxolone Being Investigated as Treatment for Tuberous Sclerosis and CDKL5 Deficiency Disorder
source: pixabay.com

Ganaxolone Being Investigated as Treatment for Tuberous Sclerosis and CDKL5 Deficiency Disorder

Marinus Pharmaceuticals is a pharmaceutical company that works to create treatments for epilepsy and other neuropsychiatric disorders. They are in the process of conducting clinical trials to evaluate the safety…

Continue Reading Ganaxolone Being Investigated as Treatment for Tuberous Sclerosis and CDKL5 Deficiency Disorder
Positive Results at End of Phase 3 Trial of Candidate Tuberous Sclerosis Complex Drug – CBD
cbd123 / Pixabay

Positive Results at End of Phase 3 Trial of Candidate Tuberous Sclerosis Complex Drug – CBD

According to a press release from the British biotechnology company GW Pharmaceuticals, the company has reported successful results at the conclusion of its phase 3 trial of tuberous sclerosis complex…

Continue Reading Positive Results at End of Phase 3 Trial of Candidate Tuberous Sclerosis Complex Drug – CBD
Study Shows We Need Better Awareness of Pediatric Onset Multiple Sclerosis to Improve Patient Care
source: pixabay.com

Study Shows We Need Better Awareness of Pediatric Onset Multiple Sclerosis to Improve Patient Care

Multiple Sclerosis (MS) was long believed to be an illness that could only affect adults. In fact, the pediatric form of this disease was not discovered until just over 10…

Continue Reading Study Shows We Need Better Awareness of Pediatric Onset Multiple Sclerosis to Improve Patient Care
Research Shows That a Facial Cream Containing Rapamycin Could Improve Facial Tumours Linked to Tuberous Sclerosis Complex
Source: Pixabay

Research Shows That a Facial Cream Containing Rapamycin Could Improve Facial Tumours Linked to Tuberous Sclerosis Complex

Research into possible facial creams containing the medicine rapamycin have found that they are effective for reducing facial tumours in people with tuberous sclerosis complex. The full article can be…

Continue Reading Research Shows That a Facial Cream Containing Rapamycin Could Improve Facial Tumours Linked to Tuberous Sclerosis Complex
Scottish Mother Prepares to Obtain Cannabidiol Oil For Her Son With Rare Epilepsy
source: pixabay.com

Scottish Mother Prepares to Obtain Cannabidiol Oil For Her Son With Rare Epilepsy

According to a story from edinburghnews.com, mother Karen Gray is about to seek access to cannabidiol oil for her five-year-old son, Murray, who has a rare type of epilepsy, Myoclonic Astatic…

Continue Reading Scottish Mother Prepares to Obtain Cannabidiol Oil For Her Son With Rare Epilepsy
Delaying Epilepsy Onset in Young Children Could Improve Other Neurological Conditions
1041483 / Pixabay

Delaying Epilepsy Onset in Young Children Could Improve Other Neurological Conditions

Scientists are investigating whether delaying the onset of epilepsy in very young children could reduce or prevent other neurological conditions such as learning difficulties and autism, reports Medical Xpress. This…

Continue Reading Delaying Epilepsy Onset in Young Children Could Improve Other Neurological Conditions
Mother’s Underground Marijuana Lab Leads to Legislative Change in Peru
source: pixabay.com

Mother’s Underground Marijuana Lab Leads to Legislative Change in Peru

The story starts in a Ana Alvarez's flat in Lima, Peru. Soon after, Ana will convert this apartment into a marijuana laboratory and underground medical center. The public will largely sympathize…

Continue Reading Mother’s Underground Marijuana Lab Leads to Legislative Change in Peru